Published on 29 May 2024 on Benzinga
Merck Reportedly Nearing $1.3B Acquisition Of EyeBio To Expand Eye-Care Market Presence - Merck & Co...
Merck & Co., Inc. MRK is reportedly on the verge of acquiring EyeBio, an eye drug company, for a sum of $1.3 billion. This acquisition is expected to significantly expand Merck’s presence in the rapidly growing eye-care market.
What Happened: The deal, which could be announced as early as Wednesday, will see Merck pay $1.3 billion in cash upfront to acquire EyeBio, a privately held biotech firm. Merck could also make additional payments of up to $1.7 billion, contingent on certain milestones, reported The Wall Street Journal on Tuesday, citing people familiar with the matter.